Cartesian Therapeutics (RNAC) Stock Gains Momentum In After-Hour Trading
Fahim Awan
April 14, 2025
Following the announcement of positive clinical trial data for its primary therapeutic candidate, Descartes-08, shares of Cartesian Therapeutics, Inc. (NASDAQ: RNAC) saw significant increases in